|
Chapter 1 Soluble Molecule Transport Within Synthetic Hydrogels in Comparison to the Native Extracellular Matrix |
|
|
1 | (30) |
|
|
|
|
1 | (1) |
|
1.2 Steady-State Diffusion |
|
|
2 | (6) |
|
1.2.1 Steady-State Diffusion Within the Native ECM |
|
|
2 | (3) |
|
1.2.2 Steady-State Diffusion Within Synthetic Hydrogels |
|
|
5 | (3) |
|
1.3 Soluble Factor Generation and Consumption |
|
|
8 | (5) |
|
1.3.1 Soluble Factor Generation and Consumption Within the Native ECM |
|
|
8 | (3) |
|
1.3.2 Soluble Factor Generation and Consumption Within Synthetic Hydrogels |
|
|
11 | (2) |
|
|
13 | (4) |
|
1.4.1 Interactions with ECM Components |
|
|
13 | (1) |
|
1.4.2 Interactions with Hydrogel Components |
|
|
14 | (3) |
|
1.5 Temporal Dependencies |
|
|
17 | (7) |
|
1.5.1 Temporal Dependencies During In Vivo Transport |
|
|
17 | (3) |
|
1.5.2 Temporal Dependencies During Transport in Synthetic Hydrogels |
|
|
20 | (4) |
|
|
24 | (2) |
|
1.6.1 In Vivo Transport by Convection |
|
|
24 | (1) |
|
1.6.2 Transport in Synthetic Hydrogels by Convection |
|
|
25 | (1) |
|
1.7 Future Directions and Concluding Remarks |
|
|
26 | (5) |
|
|
27 | (4) |
|
Chapter 2 Biocompatibility of Hydrogelators Based on Small Peptide Derivatives |
|
|
31 | (17) |
|
|
|
|
|
31 | (2) |
|
2.2 Biocompatibility of Hydrogelators in Mammalian Cells |
|
|
33 | (9) |
|
2.2.1 Biocompatibility of Hydrogelators of Conjugates of Pentapeptides and Aromatic Motifs |
|
|
33 | (3) |
|
2.2.2 Biocompatibility of Hydrogelators of N-Unsubstituted Dipeptides |
|
|
36 | (2) |
|
2.2.3 Biocompatibility of Hydrogelators of the Conjugates of Nucleobases and Peptides |
|
|
38 | (2) |
|
2.2.4 Biocompatibility of Hydrogelators of Conjugates of Nucleobases, Peptides, and Saccharides |
|
|
40 | (2) |
|
2.3 Biocompatibility of Hydrogelators in Animal Models |
|
|
42 | (3) |
|
|
45 | (3) |
|
|
45 | (3) |
|
Chapter 3 Recombinant Protein Hydrogels for Cell Injection and Transplantation |
|
|
48 | (25) |
|
|
|
|
48 | (1) |
|
3.2 Motivation: Cellular Control Though Tailored Protein Interactions |
|
|
49 | (6) |
|
3.2.1 Extracellular Protein Interactions Relevant to Cell Delivery |
|
|
50 | (2) |
|
3.2.2 Domain-Level Engineering in Recombinant Hydrogels |
|
|
52 | (3) |
|
3.3 From Concept to Protein-Engineered Cell Delivery |
|
|
55 | (3) |
|
3.4 Case Studies: Recent Developments and Applications of Recombinant Hydrogels |
|
|
58 | (8) |
|
|
58 | (3) |
|
|
61 | (2) |
|
3.4.3 Resilin-like Proteins |
|
|
63 | (1) |
|
3.4.4 Mixing-Induced Two-Component Hydrogels (MITCH) |
|
|
64 | (2) |
|
3.5 Challenges and Opportunities in Clinical Translation |
|
|
66 | (1) |
|
|
67 | (6) |
|
|
68 | (5) |
|
Chapter 4 The Instructive Role of Biomaterials in Cell-Based Therapy and Tissue Engineering |
|
|
73 | (22) |
|
|
|
|
4.1 Introduction to Cell-Based Therapies |
|
|
73 | (3) |
|
4.1.1 Potential Clinical Applications and Pharmaceutical Industry Involvement |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (4) |
|
4.2.1 Natural Biomaterials |
|
|
77 | (1) |
|
4.2.2 Synthetic Materials in Tissue Engineering Applications |
|
|
78 | (2) |
|
4.3 Biomaterials in Tissue Engineering |
|
|
80 | (15) |
|
4.3.1 Cell Response to Substrate Elasticity |
|
|
81 | (2) |
|
4.3.2 Structuring of ECM Mimics |
|
|
83 | (1) |
|
|
84 | (2) |
|
4.3.4 Proteins and Pathways |
|
|
86 | (2) |
|
4.3.5 Relevance to Regenerative Medicine |
|
|
88 | (1) |
|
|
89 | (6) |
|
Chapter 5 Microencapsulation of Probiotic Bacteria into Alginate Hydrogels |
|
|
95 | (17) |
|
|
|
|
|
95 | (2) |
|
5.2 The Chemistry of Alginates |
|
|
97 | (2) |
|
5.3 Producing Alginate Hydrogels |
|
|
99 | (4) |
|
5.4 Protecting Probiotics---Demonstrating Efficacy of Alginate Microcapsules |
|
|
103 | (3) |
|
5.5 Modifications of Alginate Hydrogels |
|
|
106 | (3) |
|
5.6 The Future of Alginate as an Immobilization Matrix for Probiotics |
|
|
109 | (3) |
|
|
110 | (2) |
|
Chapter 6 Enzyme-Responsive Hydrogels for Biomedical Applications |
|
|
112 | (23) |
|
|
|
|
112 | (3) |
|
6.1.1 Polymeric and Self-Assembling Hydrogels |
|
|
113 | (1) |
|
6.1.2 Use of Enzymes in Fabrication of Next-Generation Biomaterials |
|
|
113 | (1) |
|
6.1.3 Use of Enzymes as 'Stimuli' in Smart Materials |
|
|
114 | (1) |
|
6.2 Biocatalytic Assembly of Supramolecular Hydrogels |
|
|
115 | (9) |
|
6.2.1 Peptide-Based Hydrogels |
|
|
116 | (1) |
|
6.2.2 Biocatalytic Peptide Self-Assembly for Biomaterials Fabrication |
|
|
117 | (7) |
|
6.3 Biomedical Applications |
|
|
124 | (5) |
|
6.3.1 Controlling and Directing Cell Fate |
|
|
125 | (1) |
|
6.3.2 Imaging and Biosensing |
|
|
126 | (2) |
|
6.3.3 Controlled Drug Release |
|
|
128 | (1) |
|
6.3.4 Cell Scaffolds and Tissue Engineering |
|
|
128 | (1) |
|
6.4 Conclusions and Outlook |
|
|
129 | (6) |
|
|
130 | (5) |
|
Chapter 7 Alginate Hydrogels for the 3D Culture and Therapeutic Delivery of Cells |
|
|
135 | (36) |
|
|
|
7.1 Alginate Isolation and Gelation Chemistry |
|
|
135 | (6) |
|
7.1.1 Extraction and Purification of Alginate Polysaccharides |
|
|
136 | (1) |
|
7.1.2 Alginate Gelation Chemistry |
|
|
137 | (3) |
|
7.1.3 The Alginate Gel Structure |
|
|
140 | (1) |
|
7.2 Alginate Hydrogels as Cell Culture Scaffolds |
|
|
141 | (10) |
|
7.2.1 Regeneration of the Cornea Using Alginate-Encapsulated Corneal Cells |
|
|
141 | (1) |
|
7.2.2 Harnessing the Therapeutic Potential of Embryonic Stem Cells Using Alginate Gels |
|
|
142 | (2) |
|
7.2.3 Engineering Clinically Viable Trabecular Bone and Cartilage Using Alginate Gel Scaffolds |
|
|
144 | (4) |
|
7.2.4 Alginate Gels for Cardiac Tissue Repair: Development of the Cardiac Patch |
|
|
148 | (1) |
|
7.2.5 Alginate/Endothelial Progenitor Cell Platforms for Therapeutic Angiogenesis and Neovascularization |
|
|
149 | (1) |
|
7.2.6 The Construction of Neural Prosthetics and Culture Systems Using Alginate Gels |
|
|
150 | (1) |
|
7.3 The Influence of Alginate Gel Biophysical and Biochemical Properties on Cell Phenotype |
|
|
151 | (8) |
|
7.3.1 The Effect of Alginate Gel Biophysical Properties on Encapsulated Cells |
|
|
152 | (3) |
|
7.3.2 The Effect of Biochemically Modified Alginate Gels on Cells |
|
|
155 | (4) |
|
|
159 | (12) |
|
|
164 | (7) |
|
Chapter 8 Mechanical Characterization of Hydrogels and its Implications for Cellular Activities |
|
|
171 | (20) |
|
|
|
|
|
|
171 | (2) |
|
8.2 Hydrogel Characterization Techniques |
|
|
173 | (3) |
|
8.3 Effect of Hydrogel Mechanical Properties on Cellular Activities |
|
|
176 | (2) |
|
8.4 Effect of Cellular Activity on Hydrogel Properties |
|
|
178 | (3) |
|
8.5 Mechanical Properties as a Marker of Cellular Activities |
|
|
181 | (3) |
|
8.5.1 Indicator of Differentiation Status |
|
|
181 | (1) |
|
8.5.2 Indicator of Cell Viability and Contractility |
|
|
182 | (1) |
|
8.5.3 Indicator of Network Structure in the Hydrogel |
|
|
183 | (1) |
|
8.6 Strategies for Improving the Mechanical Properties of Hydrogels |
|
|
184 | (3) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
8.6.4 Orientation of Fibrous Components |
|
|
186 | (1) |
|
8.6.5 Micro- and Nanopatterning |
|
|
186 | (1) |
|
8.6.6 Magnetically Aligned Collagen |
|
|
186 | (1) |
|
8.6.7 Electrospinning of Nanofibres |
|
|
187 | (1) |
|
|
187 | (4) |
|
|
188 | (3) |
|
Chapter 9 Extracellular Matrix-Like Hydrogels for Applications in Regenerative Medicine |
|
|
191 | (25) |
|
|
9.1 A Brief Introduction to the Field of Biomaterials |
|
|
191 | (1) |
|
9.2 Hydrogel Biomaterial Types |
|
|
192 | (2) |
|
9.2.1 Synthetic Polymer Hydrogels |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
194 | (1) |
|
9.3 Implementations in Regenerative Medicine |
|
|
194 | (14) |
|
|
195 | (3) |
|
9.3.2 Primary Cell and Tissue Culture |
|
|
198 | (2) |
|
|
200 | (1) |
|
9.3.4 Tissue Engineering Ex Vivo/In Vitro |
|
|
201 | (7) |
|
9.4 Future Potential and Implications |
|
|
208 | (1) |
|
|
209 | (7) |
|
|
209 | (7) |
Subject Index |
|
216 | |